Making science workFind out how

Making science work

Find out how

2nd Conference of the Patient Centric Medicines Initiative (PaCeMe In)  | CN 6782

Tailor medicines for older patients in pharmaceutical development: From new regulations to a rational science based process 05.06. - 06.06.2019 | Berlin, Germany

Venue

Abba Berlin Hotel
Lietzenburger Str. 89
10719 Berlin
Phone:0049 30 887 186 0

Workshop programme for download

Description

As an outcome of the 1st Conference on patient centric product development, the Patient Centric Medicine (PaCeMe) initiative was established early 2018 as a multidisciplinary industrial-academic collaboration to develop practical guidance to comply with future patient centric product development.

The 2nd conference on patient centric product development is titled:
Tailor medicines for older patients in pharmaceutical development: From new regulations to a rational science based process

The conference bring together key opinion leaders from different disciplines including patient representatives to provide their expertise and thoughts as well as to discuss the results of the PaCeMe Initiative stakeholders in workshops with the attendees.

Target groups

Employees

  • of the pharmaceutical industry (formulation development, product development, clinical and commercial manufacturing, regulatory affairs, medical science and marketing)
  • and academy (pharma technology and students).

Hospital pharmacists, community pharmacists as well as regulatory authorities.

Objective

The objective is to provide a pragmatic road map and achieve a general consensus that we can do it and even better.

The multidisciplinary and distinguished speaker panel will touch on different aspects of patient centric drug product development, its importance for effectiveness and drug safety, and especially how this can become an integral mind set for drug product development.

Areas that will be discussed in details are:

  • Ethical aspects of patient centric products for older and multimorbid patients
  • Patient characteristics and needs from medical, epidemiological, sociological and pharmaceutical practice
  • Thoughts and considerations on ongoing and future regulation
  • Case studies of involving patients in drug development and product design
  • Successful industrial development of a patient centric drug product

Finally, all conference attendees will be involved by a moderated interactive discussion on a proposed “road map” for patient centric drug product development as a way forward to a scientific rational, meaningful and commercially viable “road map” for patient centric product design.

Registration fee

  Price
Industry 1,490.00 €
Authority / University 745.00 €
Students 178.00 €
All prices free of VAT

Organizer(s)

APV-Office

Dr. Martin Bornhöft
Phone: +49 6131 9769-0
Fax: +49 6131 9769-69
E-mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/